Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities:    
Net income $ 3,051 $ 480
Adjustments to reconcile net income to net cash used provided (used) by operating activities:    
Depreciation 1,549 1,724
Amortization of intangible assets 891 1,238
Amortization of actuarial losses 421 336
Amortization of debt issuance costs 119 93
Equity-based compensation expense 625 312
Deferred income taxes 1,162 174
(Increase) decrease in operating assets:    
Accounts receivable (4,947) 38
Unbilled revenue 4,620 (5,283)
Inventories (734) (2,560)
Prepaid expenses and other current and non-current assets (1,343) (782)
Income taxes receivable (489) (136)
Operating lease assets 589 901
Prepaid pension asset (144) (325)
Increase (decrease) in operating liabilities:    
Accounts payable (6,451) 3,730
Accrued compensation, accrued expenses and other current and non-current liabilities 5 553
Customer deposits 13,503 544
Operating lease liabilities (529) (840)
Long-term portion of accrued compensation, accrued pension and postretirement benefit liabilities 0 (595)
Net cash provided (used) by operating activities 11,898 (398)
Investing activities:    
Purchase of property, plant and equipment (3,312) (1,176)
Proceeds from disposal of property, plant and equipment 38 0
Net cash used by investing activities (3,274) (1,176)
Financing activities:    
Principal repayments on debt (1,020) (3,511)
Proceeds from the issuance of debt 0 5,000
Repayments on financing lease obligations (147) (136)
Payment of debt issuance costs 0 (122)
Issuance of common stock 225 0
Purchase of treasury stock (57) (22)
Net cash (used) provided by financing activities (999) 1,209
Effect of exchange rate changes on cash (82) (254)
Net increase (decrease) in cash and cash equivalents 7,543 (619)
Cash and cash equivalents at beginning of period 18,257 14,741
Cash and cash equivalents at end of period $ 25,800 $ 14,122